Substance use : research and treatment最新文献

{"title":"Low-Threshold Buprenorphine in Non-Traditional Settings: A Scoping Review.","authors":"Anna Patterson, Zachary Davis, Mackenzie Smith, Nihmotallahi Adebayo, Madelyn Perez, Miriam Guzman, Tina Griffin, Dennis Watson, Elisabeth Poorman, Niranjan S Karnik, Sarah Messmer","doi":"10.1177/29768357251371854","DOIUrl":"10.1177/29768357251371854","url":null,"abstract":"<p><strong>Background: </strong>Despite the continuing opioid overdose crisis, the majority of those diagnosed with opioid use disorder (OUD) are not engaged in treatment due to various barriers. Low-threshold buprenorphine programs are designed to reduce treatment barriers. Key tenets of these programs are a harm reduction approach, same-day entry, flexibility, and accessibility. The development of novel programs has expanded low-threshold treatment into mobile units, syringe service programs, and community centers.</p><p><strong>Objective: </strong>This scoping review aims to describe approaches taken by programs in non-clinical settings by identifying key components of delivery models, implementation barriers and facilitators, and outcomes. Given the diverse nature of the literature on these programs, a scoping review was selected to review outcomes and to identify gaps.</p><p><strong>Methods: </strong>A protocol following the PRISMA-ScR guidelines was developed to systematically search 5 databases: Medline, Embase, CINAHL, PsycInfo, and Web of Science. Articles published prior to January 31, 2024 that described buprenorphine programs operating outside traditional healthcare settings were included.</p><p><strong>Results: </strong>The search identified 18 784 articles, including 147 in full-text review, with 41 meeting eligibility criteria. Common program types encompassed syringe service, mobile, community center, and street medicine. All programs emphasized community partnerships as key implementation facilitators and noted funding is urgently needed.</p><p><strong>Conclusion: </strong>Low-threshold buprenorphine programs are an innovative way to deliver OUD treatment to people who otherwise may not have access to and/or engage in treatment. Future efforts should determine which outcomes are most important to people who use drugs, standardize outcome measurements, and implement programs tailored to help communities meet those outcomes.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251371854"},"PeriodicalIF":0.0,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing an Inpatient Substance Use Disorder Program in a Middle-Income Country: The Experience of Sbrana Psychiatric Hospital, Botswana.","authors":"Anthony A Olashore, Selebogo M Moremi, Taboka Maphorisa, Lecha Masego, Mpho L Hubona","doi":"10.1177/29768357251371406","DOIUrl":"10.1177/29768357251371406","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of substance use disorders (SUDs) is rising globally, significantly affecting public health. These disorders are associated with reduced quality of life, comorbid mental health conditions, and increased risk of infectious diseases such as HIV. This paper describes the development and implementation of group therapy as an intervention for SUDs in a resource-constrained setting.</p><p><strong>Program description: </strong>An 8-week inpatient group therapy program was established at Sbrana Psychiatric Hospital in Botswana. The interdisciplinary team includes a social worker, psychologist, occupational therapist, psychiatric residents, and a psychiatrist. To date, 9 cohorts comprising 55 patients have fully participated. The average age was 35 years; most were males (61%), with alcohol being the most used substance, followed by crack cocaine. Of these, 21 have remained abstinent for at least 3 months and reintegrated into society, 11 have relapsed, and 23 are lost to follow-up.</p><p><strong>Program insights: </strong>Challenges encountered include client dropouts, poor reintegration into the community, limited follow-up systems, and financial constraints. Key components contributing to the program's impact include peer support, relapse prevention, coping strategies, psychoeducation on triggers, and elements of the 12-step recovery model.</p><p><strong>Conclusion: </strong>Program improvement areas include strengthening follow-up through objective measures, such as urine drug testing, and incorporating structured wellness and recreational activities to support recovery.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251371406"},"PeriodicalIF":0.0,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acceptability of a Telehealth Smoking Harm Reduction Intervention Using E-cigarettes Among Cigarette Smokers With Opioid Use Disorder: A Qualitative Analysis.","authors":"Omar El-Shahawy, Adetayo Fawole, Brian Kang, Mohsen Abbasi-Kangevari, Mariana Braga, Nada Hamade, Mohamed Doucoure, Jennifer Cantrell, Scott Sherman, Svetlana Shpiegel, Daniel Schatz, Elizabeth R Stevens","doi":"10.1177/29768357251337050","DOIUrl":"10.1177/29768357251337050","url":null,"abstract":"<p><strong>Background: </strong>Electronic cigarettes (EC) may serve as a potential smoking harm reduction tool by addressing both nicotine and behavioral dependence. This qualitative study reports the feasibility and acceptability of using EC and telehealth counseling among individuals in treatment programs for opioid use disorders (OUD) who smoke combustible cigarette, and was conducted as part of a randomized controlled trial. We report findings among participants in the EC arm.</p><p><strong>Methods: </strong>Qualitative interviews were conducted from March to May 2021. The interviews were audio recorded, transcribed, and de-identified. An inductive approach guided by the Theoretical Framework of Acceptability was used. We developed and refined a codebook through a collaborative iterative process and team discussions. Five analysts coded the transcripts using Quirkos, with independent double coding for each transcript to achieve consensus and ensure inter-coder reliability. In-depth thematic analysis was conducted via synthesizing relevant codes that were described and exemplified using representative quotes. Saturation was achieved when no additional codes emerged.</p><p><strong>Results: </strong>Eleven participants randomized to EC were interviewed: average age = 55 years (range = 39-69), 88% were male, 41% non-Hispanic black, and 35% non-Hispanic white. Four main themes identified included inciting sense of accountability toward cigarette smoking reduction; acknowledging the value of telehealth counseling; noting positive attributes such as addressing craving, as well as challenges in utilizing EC such as the need to remember charging the EC; and finally, participants' expression of the satisfaction with their perceived improvements in their health and other behavioral aspects.</p><p><strong>Conclusion: </strong>The intervention combining telehealth counseling with EC was perceived as acceptable and helpful for reducing cigarette smoking, as well as resulting in other positive health benefits. ECs were easy to use and seemed to address craving; albeit with some challenges that can be addressed in future trials. EC combined with telehealth counseling carries great promise in smoking reduction among individuals with OUD.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251337050"},"PeriodicalIF":0.0,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring Socio-Ecological and Structural Factors Among Black Men in Rural South Carolina to Inform Substance Use Disorder Interventions: A Qualitative Study.","authors":"Serge R Wandji, Jean E Davis, Monica H Swahn, Mohan Madisetti, Charlene Pope","doi":"10.1177/29768357251349918","DOIUrl":"10.1177/29768357251349918","url":null,"abstract":"<p><strong>Objective: </strong>This formative study aimed to explore socio-ecological and structural determinants that influence substance use disorders (SUD) among Black men in rural areas of South Carolina (USA) and inform the design of culturally relevant community-based interventions.</p><p><strong>Methods: </strong>Black adult men (N = 15; ages 33-66 years) with known SUD were recruited from outpatient treatment centers, homeless shelters, and via community outreach initiatives within rural areas of South Carolina. Written informed consent was obtained, and interviews were conducted using a structured interview guide. Interview data was audio-recorded, coded and analyzed until consensus was reached on emergent themes. Data were collected between June 2023 and May 2024.</p><p><strong>Results: </strong>Five primary themes emerged: perceptions and experiences with substance use, contributing factors to substance use, determinants of treatment acceptance, and relapse triggers. Findings from this work highlight barriers such as financial constraints, peer influence, social dynamics, and systemic inequalities that hinder SUD treatment engagement for Black men in the rural South. Facilitators such as community and familial support, cultural considerations, and self-awareness were identified as critically important for encouraging treatment acceptance.</p><p><strong>Conclusion: </strong>This exploratory study provides insight into the socio-cultural and structural complexities faced by Black men in rural South Carolina (USA) regarding SUD treatment and relapse prevention. Our findings support the call for culturally sensitive, community-driven research and interventions that address both personal and systemic challenges. Larger and interdisciplinary studies are needed to address urgent prevention and treatment gaps, and pervasive disparities in SUD treatment outcomes for Black men in medically underserved rural communities.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251349918"},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alcohol Consumption Impacts Liver Fibrosis Progression in Minority of Patients Screened for Hepatitis C at Drug Treatment Centers.","authors":"Alberto Hernández-Bustabad, Dalia Morales-Arraez, Ruth Ramos, Luz Goretti Santiago Gutiérrez, María Jesús Medina Alonso, Zaida Ramos-Marrero, Victor Pérez Pérez, Eva Molina Carballo, Felicitas Diaz-Flores, Julia Nazco, Fernando Gutiérrez, Manuel Hernández-Guerra","doi":"10.1177/29768357251347821","DOIUrl":"10.1177/29768357251347821","url":null,"abstract":"<p><strong>Background & aims: </strong>Hepatitis C virus (HCV) infection is a prevalent disease at drug treatment centers (DTC). Alcohol abuse may also contribute to liver fibrosis at DTC, which may affect the prescription of HCV therapy. This study evaluated the risk of alcohol intake and other predictive factors for fibrosis progression.</p><p><strong>Methods: </strong>An on-site dried-blood-spot (DBS) testing program for hepatitis C care at DTC from 2017 to 2019 was used to identify patients with previous HCV-antibody testing and fibrosis score data. Patients were grouped based on RNA status, alcohol intake and advanced liver disease (ALD ⩾ F3). Fibrosis progression was assessed using APRI and FIB-4. Kaplan-Meier and Cox-regression analyses were performed.</p><p><strong>Results: </strong>Positive HCV RNA patients (n = 138) exhibited a higher rate of ALD (11% vs 2.2%, <i>P</i> < .001) and a higher risk of fibrosis progression during follow-up (HR = 3.14, 95% CI: 1.2-8.2) than patients who did not have an infection (n = 230). Overall, 25% (n = 84) reported high-risk alcohol consumption, which was associated with an increased risk of ALD in patients with RNA positivity (HR = 3.2; 95% CI: 1.1-9.1). Alcohol consumption at any dose regardless of HCV infection status was not associated with ALD. Age, high-risk alcohol consumption, and RNA positivity were independent factors for progression to ALD.</p><p><strong>Conclusions: </strong>Patients with active HCV infections at DTC have an increased risk for ALD compared to patients without HCV. High-risk alcohol consumption is present in a minority of patients aggravating fibrosis. These results suggest that HCV treatment should not be delayed at DTC regardless of alcohol consumption.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251347821"},"PeriodicalIF":0.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144593388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How Much Treatment are Adolescents Receiving in Specialised Substance Use Healthcare in Sweden? Age and Cohort Trends.","authors":"Patrik Karlsson, Mats Ekendahl, Philip Lindner","doi":"10.1177/29768357251351758","DOIUrl":"10.1177/29768357251351758","url":null,"abstract":"<p><strong>Background: </strong>There is little systematic research on what adolescents are provided within specialised substance use treatment. This study explored trends in treatment received (number of outpatient treatment visits and inpatient treatment episodes) according to year and age at first contact among adolescents who were enrolled at Sweden's largest treatment provider, the Maria Ungdom Clinic in Stockholm, between 2011 and 2021.</p><p><strong>Methods: </strong>The data were derived from electronic health records for all patients (n = 29 967) who were in contact with Maria Ungdom Stockholm between 2011 and 2021. Negative binomial regressions estimated the association between year cohort and age at first contact and number of outpatient visits respective number of inpatient episodes. We also tested whether trends according to year cohort and age at first contact were moderated by sex and treatment type.</p><p><strong>Results: </strong>Patients in earlier cohorts and those who were younger at first contact had more outpatient visits. A similar association with age at first contact was observed for inpatient treatment, but was less evident for year cohort. Differences in outpatient visits according to year cohort and age at first contact were mainly observed in patients enrolled in both outpatient and inpatient treatment, and the same held true for differences in number of inpatient episodes according to age at first contact. Regression models that adjusted for potential different exposure time found a higher treatment rate among later cohorts and patients who were older at first contact.</p><p><strong>Conclusion: </strong>Patients in the earlier year cohorts and who were at younger age at first contact with Maria Ungdom received most treatment. However, later cohorts and patients who were at an older age at first contact with Maria Ungdom had a higher treatment rate, suggesting that these groups were provided with a more intensive treatment.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251351758"},"PeriodicalIF":0.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12227927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144577549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring Nicotine Dependence Among People Using Methamphetamine During Methadone Maintenance Treatment in Vietnam.","authors":"Nguyen Truong Giang, Nguyen Bich Diep, Nguyen Thu Trang, Pham Thanh Luan, Hoang Thi Hai Van, Do Van Dung, Michael Li, Chunqing Lin, Li Li, Steve Shoptaw, Le Minh Giang","doi":"10.1177/29768357251347819","DOIUrl":"10.1177/29768357251347819","url":null,"abstract":"<p><strong>Introduction: </strong>Cigarette smoking is common among individuals with substance use disorders and those undergoing addiction treatment. Cigarette use is highly comorbid with methamphetamine use, and among individuals who co-use methamphetamine and opioids, nicotine dependence may further complicate smoking cessation efforts. This study examines nicotine dependence levels and associated factors among people who use methamphetamine undergoing methadone maintenance treatment (MMT) in Vietnam.</p><p><strong>Methods: </strong>This cross-sectional analysis utilized baseline data from 667 participants enrolled in a randomized controlled trial designed to evaluate the effectiveness of various combinations of behavioral evidence-based interventions for methamphetamine use among patients on MMT in Vietnam (STAR-OM R01DA050486). Data on levels of nicotine dependence and other covariates including demographic, health status, treatment characteristics and substance use were collected. Nicotine dependence was measured using the Fagerström Test for Nicotine Dependence, with a score of 6 or higher indicating high dependence. Logistic regression estimated the association between nicotine dependence and various psychosocial and behavioral factors.</p><p><strong>Results: </strong>Overall, 96.7% of the participants were current smokers with 247 of them (38.3%) exhibiting high nicotine dependence. Greater severity of methamphetamine withdrawal symptoms (OR: 1.03; 95% CI: 1.01-1.05) and a high risk of depression, anxiety or stress (OR: 1.76; 95% CI: 1.14-2.72) were associated with increased odds of high nicotine dependence. Conversely, older age at onset of methamphetamine use was associated with lower odds of high nicotine dependence.</p><p><strong>Conclusions: </strong>Cigarette smoking was highly prevalent among individuals using methamphetamine during MMT, with many exhibiting high nicotine dependence. Providing smoking cessation support with efforts to manage methamphetamine withdrawal symptoms, could help improve cessation outcomes.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251347819"},"PeriodicalIF":0.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144500081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Qualitative Study to Explore Feasibility of Implementing Seeking Safety and Trauma-Sensitive Yoga.","authors":"Teresa Naseba Marsh, Farah Tahsin, Kristen A Morin, Tammy Linekar, Harry Jones, David C Marsh","doi":"10.1177/29768357251350869","DOIUrl":"10.1177/29768357251350869","url":null,"abstract":"<p><strong>Background: </strong>Seeking Safety (SS) is an evidence-based intervention that benefits patients living with co-occurring PTSD and SUD. Trauma Sensitive Yoga (TSY) has been found to be another beneficial treatment for this patient population. In this study, we examine the feasibility of implementing both SS and TSY within a residential addiction treatment program to support this patient population.</p><p><strong>Methods: </strong>We conducted a qualitative prospective evaluation at the Jubilee Treatment Centre in Timmins Ontario from March 2023 to October 2023. Staff members of this center delivered the SS intervention and the TSY was delivered virtually by a certified yoga teacher to the participants. The data sources included patient data, focus groups, and treatment satisfaction surveys to evaluate the effect of this blended intervention on study participants and program staff. A descriptive statistical analysis as well a thematic analysis was conducted to analyze both quantitative and qualitative data, respectively.</p><p><strong>Results: </strong>A total of 45 individuals, participated in this 6-month-long intervention. The average age of the participants was 37.88. 84.44% of participants experienced mental health problems in the last 90 days, and 80% used substances in the last 90 days. The paired <i>t</i>-test analysis indicated a significant difference in Trauma Symptoms Checklist 40 scores before and after the intervention.</p><p><strong>Conclusion: </strong>This study provided valuable insights into participants' experiences of participating in this innovative intervention. The finding can benefit future researchers who seek to implement similar programs to support individuals with PTSD and SUD.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251350869"},"PeriodicalIF":0.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144500080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pain Management Strategies for Patients Receiving Extended-Release Buprenorphine for Opioid Use Disorder: A Scoping Review.","authors":"Pouya Azar, Jane J Kim, Farbod Azarmju, Koviya Sirohi, Jessica Machado, Anthony Lau, Jacky Siu, Martha J Ignaszewski, Julio S G Montaner, Michael Krausz","doi":"10.1177/29768357251343612","DOIUrl":"10.1177/29768357251343612","url":null,"abstract":"<p><strong>Objective: </strong>Pain is a significant clinical challenge among patients with opioid use disorder (OUD), and management strategies remain diverse and controversial. This scoping review aimed to describe and evaluate the different types of pharmacologic pain management strategies for patients who are prescribed extended-release buprenorphine (BUP-XR) for OUD and experiencing pain.</p><p><strong>Methods: </strong>The databases Ovid Medline, EMBASE, CINAHL, Web of Science, and PsycInfo were searched from their inception to February 2025 for relevant articles. All articles that discuss the treatment of acute or chronic pain among patients receiving BUP-XR were included. Data on the key outcomes of pain severity, related functioning, patient satisfaction, and adverse events were extracted and study quality was rated independently by the authors.</p><p><strong>Results: </strong>The initial search yielded 980 articles. Of those, 56 were assessed for full-text review and a total of 6 articles met inclusion criteria for the study. The overall strength of the evidence was poor, consisting mainly of case series and case reports. Most studies achieved adequate pain control through the continuation of BUP-XR and the combination of full opioid agonists and non-opioid adjuncts, adjunct use of nonsteroidal anti-inflammatory drugs, conversion to sublingual buprenorphine, or performing surgery at trough serum buprenorphine concentration. No cases of respiratory depression or toxicity were observed.</p><p><strong>Conclusions: </strong>This review confirmed that clear guidelines on how to support pain management in BUP-XR treatment have yet to be identified. The majority of clinicians favored a multimodal analgesic approach combining opioids, non-opioid analgesics, and regional anesthesia. Further studies, including high-quality evidence through randomized controlled trials, are needed to find and evaluate optimal adjunctive medications and define overall strategies.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251343612"},"PeriodicalIF":0.0,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171288/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Promoting Health Equity Among People With Opioid Use Disorder and Serious Mental Illness Through the Chronic Disease Self-Management Program.","authors":"Elizabeth Siantz, Leopoldo J Cabassa, Adam J Gordon","doi":"10.1177/29768357251342749","DOIUrl":"10.1177/29768357251342749","url":null,"abstract":"<p><p>People with opioid use disorder (OUD) experience higher prevalence of serious mental illness (e.g., schizophrenia and bipolar disorder) and chronic disease (e.g., diabetes) relative to the general population, less access to high quality health care, and limited access to evidence-based treatments that promote self-management of chronic health conditions. The Chronic Disease Self-Management Program is a widely used patient education intervention that imparts disease knowledge and self-management skills to people with a range of medical conditions. In this Perspective Column, a multidisciplinary team of community-based researchers representing the fields of social work and addiction medicine argue that implementing the Chronic Disease Self-Management Program in a primary care environment is a promising way to build the self-management skills of people with OUD and co-occurring mental illness and chronic disease.</p>","PeriodicalId":517405,"journal":{"name":"Substance use : research and treatment","volume":"19 ","pages":"29768357251342749"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144201286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}